Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial

Michael J. Morris, Yohann Loriot, Christopher J. Sweeney, Karim Fizazi, Charles J. Ryan, Daniel H. Shevrin, Emmanuel S. Antonarakis, Neeta Pandit-Taskar, Désirée Deandreis, Heather A. Jacene, Hubert Vesselle, Oana Petrenciuc, Cindy Lu, Jorge A. Carrasquillo, Celestia S. Higano

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial'. Together they form a unique fingerprint.

Medicine & Life Sciences